Oxford Immunotec Global PLC Contracts & Agreements
89 Contracts & Agreements
- Business Finance (34 contracts)
- Business Operations (8)
- Human Resources (19)
- Intellectual Property (1)
- Real Estate (4)
- Uncategorized (23)
- Implementation Agreement, dated January 7, 2021, by and among the Company, Bidder and Bidco (Filed With SEC on January 7, 2021)
- Third Amendment to Purchase Agreement between Mabtech AB and Oxford Immunotec Limited, dated June 17, 2020 (Filed With SEC on August 4, 2020)
- Description of Ordinary Shares (Filed With SEC on March 6, 2020)
- Employment Agreement dated August 28, 2017 between Oxford Immunotec, Inc. and Stefan Linn (Filed With SEC on March 6, 2020)
- First Amendment to the Amended and Restated Supply and Reseller Agreement, dated November 14, 2019, between Life Technologies Corporation and Oxford Immunotec Limited (Filed With SEC on November 20, 2019)
- Employment Agreement, dated April 8, 2019, between Oxford Immunotec USA, Inc. and Matthew McLaughlin (Filed With SEC on August 6, 2019)
- Sixth Amendment to Distributorship Agreement among Oxford Immunotec Limited, Fosun Long March Medical Science Co. Ltd. and Shanghai Xin Chang Medical Device Co. Ltd, dated July... (Filed With SEC on August 6, 2019)
- Amendment to the Agreement to Purchase Test Kits and Accessories between Oxford Immunotec USA, Inc. and Quest Diagnostics Incorporated dated June 12, 2019 (Filed With SEC on June 14, 2019)
- Supplier Agreement dated January 7, 2019 between Millipore (UK) Ltd. and Oxford Immunotec Limited (Filed With SEC on March 28, 2019)
- Amended and Restated Supply and Reseller Agreement dated January 9, 2019 between Life Technologies Corporation and Oxford Immunotec Limited (Filed With SEC on March 28, 2019)
- Separation Agreement dated March 8, 2019 between Richard A. Wenstrup and Oxford Immunotec USA, Inc (Filed With SEC on March 28, 2019)
- Fifth Amendment to Distributorship Agreement between Oxford Immunotec, Ltd., Fosun Long March Medical Science Co. Ltd. and Shanghai Xin Chang Medical Device Co. Ltd. entered into... (Filed With SEC on November 9, 2018)
- Form of Special Bonus Agreement, U.S. Employees (Filed With SEC on November 9, 2018)
- Form of Special Bonus Agreement, U.K. Employees (Filed With SEC on November 9, 2018)
- Limited Liability Company Interest Purchase Agreement, dated September 25, 2018, by and among Oxford Immunotec Global PLC, Quest Diagnostics Incorporated, Oxford Immunotec Limited... (Filed With SEC on September 25, 2018)
- Fourth Amendment to Distributorship Agreement between Oxford Immunotec, Ltd., Fosun Long March Medical Science Co. Ltd. and Shanghai Xin Chang Medical Device Co. Ltd. entered into... (Filed With SEC on July 31, 2018)
- Second Amendment to Purchase Agreement between Mabtech AB and Oxford Immunotec Limited dated November 17, 2017 (Filed With SEC on February 27, 2018)
- Third Amendment to Distributorship Agreement between Oxford Immunotec, Ltd., Fosun Long March Medical Science Co. Ltd. and Shanghai Xin Chang Medical Device Co. Ltd. entered into... (Filed With SEC on February 27, 2018)
- Oxford Immunotec Global PLC 2013 Amended Share Incentive Plan (Filed With SEC on February 27, 2018)
- Form of Unapproved Stock Option Award (Double Trigger) under the Oxford Immunotec Global PLC 2013 Share Incentive Plan (Filed With SEC on February 27, 2018)
- Form of Employment Agreement for Senior Executives (Filed With SEC on February 27, 2018)
- Second Amendment to Supply Agreement, dated September 1, 2017, between StemCell Technologies Canada Inc. f/k/a StemCell Technologies and Oxford Immunotec Ltd (Filed With SEC on October 31, 2017)
- OXFORD IMMUNOTEC GLOBAL PLC 2,500,000 Ordinary Shares Underwriting Agreement (Filed With SEC on August 18, 2017)
- AMENDMENT TO MARKETING AUTHORIZATION HOLDER AGREEMENT (“Amendment 3”) (Filed With SEC on July 28, 2017)
- SECOND AMENDMENT TO DISTRIBUTORSHIP AGREEMENT (Filed With SEC on March 1, 2017)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 1, 2016)
- CREDIT, SECURITY AND GUARANTY AGREEMENT (TERM LOAN) dated as of October 4, 2016 by and among OXFORD IMMUNOTEC, INC., as Borrower, OXFORD IMMUNOTEC GLOBAL PLC and OXFORD IMMUNOTEC... (Filed With SEC on October 7, 2016)
- Purchase Agreement between Imugen, Inc. and Oxford Immunotec, Inc. Dated as of June 23, 2016 TABLE OF CONTENTS (Filed With SEC on July 6, 2016)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on May 4, 2016)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on May 4, 2016)
- FORM OF AMENDMENT TO OFFICER RESTRICTED SHARE AWARD (Filed With SEC on March 1, 2016)
- 2013 Approved Company Share Option Plan Sub-Plan to the Oxford Immunotec Global PLC Share Incentive Plan FORM OF APPROVED OPTION CERTIFICATE FOR APPROVED OPTION (Filed With SEC on March 1, 2016)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on August 4, 2015)
- OXFORD IMMUNOTEC GLOBAL PLC [] Ordinary Shares Underwriting Agreement (Filed With SEC on November 14, 2013)
- Rules of the Oxford Immunotec Global PLC 2013 Share Incentive Plan Adopted by the Board on October 16, 2013 Rules of the Oxford Immunotec Global PLC 2013 Share Incentive Plan (as... (Filed With SEC on November 14, 2013)
- Signature(s) Guaranteed:Medallion Guarantee Stamp (Filed With SEC on November 8, 2013)
- REGISTRATIONRIGHTS AGREEMENT dated [ ], 2013 by and among Oxford Immunotec Global PLC and certain shareholders (Filed With SEC on November 8, 2013)
- DEED OF INDEMNITY (Filed With SEC on November 8, 2013)
- DEED OF INDEMNITY (Filed With SEC on November 8, 2013)
- DIRECTOR STOCK OPTION AWARD granted under Appendix B to the OXFORD IMMUNOTEC GLOBAL PLC 2013 SHARE INCENTIVE PLAN (Filed With SEC on November 8, 2013)
- Deed of Novation of Agreement for Services (Filed With SEC on November 8, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 5, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 5, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on November 5, 2013)
- OXFORD IMMUNOTEC GLOBAL PLC INCENTIVE PLAN (Filed With SEC on November 4, 2013)
- LETTER OF APPOINTMENT FOR A NON-EXECUTIVE DIRECTOR (Filed With SEC on November 4, 2013)
- OXFORD IMMUNOTEC GLOBAL PLC MANAGEMENT INCENTIVE COMPENSATION PLAN FOR FISCAL YEARS 2012 AND 2013 (Filed With SEC on November 4, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 25, 2013)
- ooOoo (Filed With SEC on October 25, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 15, 2013)
- WARRANT TO PURCHASE STOCK (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- Office of Technology Transfer and Business Development One Worlds Fair Drive, Suite 2100, Somerset, New Jersey 08873 Tel: 732 ###-###-#### Fax: 732 ###-###-#### (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- Page 2 of 2 (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [***] AND HASBEEN FILED SEPARATELY WITH THE SECURITIES AND... (Filed With SEC on October 15, 2013)
- Dated 2008 Counterpart Lease between MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited and Oxford lmmunotec Limited relating to Units 115 Band D Milton Park... (Filed With SEC on October 15, 2013)
- Dated 8 August 2007 MEPCMILTON PARK NO. 1 LIMITED and MEPC MILTON PARK NO. 2 LIMITED and OXFORD IMMUNOTEC LIMITED Counterpart LEASE of Unit 94C Milton Park PRESCRIBED CLAUSES (Filed With SEC on October 15, 2013)
- Dated 23 December 2009 Counterpart Deed of Variation between MEPC MiltonPark No. 1 Limited and MEPC Milton Park No. 2 Limited and Oxford lmmunotec Limited relating to Unit 94C... (Filed With SEC on October 15, 2013)
- Dated 4th May 2012 Deed of Variation between MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited and Oxford ImmunotecLimited relating to Units 115 B and D Milton Park (Filed With SEC on October 15, 2013)
- Dated 4th May 2012 Deed of Variation between MEPC Milton Park No. 1 Limited and MEPC Milton Park No. 2 Limited and Oxford lmmunotec Limited relating to Unit 94C Milton Park (Filed With SEC on October 15, 2013)
- OFFICE LEASE AGREEMENT BETWEEN NORMANDY NICKERSON ROAD, LLC (LANDLORD) AND OXFORD IMMUNOTEC, INC. (TENANT) TABLE OF CONTENTS (Filed With SEC on October 15, 2013)
- STANDARD COMMERCIAL LEASE ARTICLE 1.00 BASIC LEASE TERMS (Filed With SEC on October 15, 2013)
- OXFORD IMMUNOTEC, INC. LOAN ANDSECURITY AGREEMENT (Filed With SEC on October 15, 2013)
- Oxford Immunotec Limited AMENDED AND RESTATED 2008 STOCK INCENTIVE PLAN (Filed With SEC on October 15, 2013)
- OXFORD IMMUNOTEC LIMITED INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER AMENDED AND RESTATED 2008 STOCK INCENTIVE PLAN FOR NON-CALIFORNIA OPTION HOLDERS (Filed With SEC on October 15, 2013)
- OXFORD IMMUNOTEC LIMITED NONSTATUTORY STOCK OPTION AGREEMENT GRANTED UNDER AMENDED AND RESTATED 2008 STOCK INCENTIVE PLAN FOR NON-CALIFORNIA OPTION HOLDERS (Filed With SEC on October 15, 2013)
- OXFORD IMMUNOTEC LIMITED ENTERPRISE MANAGEMENT INCENTIVE STOCK OPTION AGREEMENT GRANTED UNDER THE AMENDED AND RESTATED 2008 STOCK INCENTIVE PLAN FOR UK QUALIFYING EMPLOYEES (Filed With SEC on October 15, 2013)
- Dated 21st October 2002 OXFORD IMMUNOTEC LIMITED (1) and DR P WRIGHTON-SMITH (2) SERVICE AGREEMENT (Filed With SEC on October 15, 2013)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 15, 2013)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on October 15, 2013)
